Sponsor Pipeline

Xentria, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT06169397
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis		 date change Primary completion moved earlier: 2029-01 -> 2026-11
2026-07-31 NCT06169397
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis		 date change Completion moved earlier: 2029-01 -> 2026-11
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06169397 An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis Pulmonary Sarcoidosis Enrolling by Invitation
Phase 1/2
NCT05890729 A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis Pulmonary Sarcoidosis Recruiting
NCT07680166 A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients… Pulmonary Sarcoidosis Not Yet Recruiting
Get alerts when Xentria, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free